Intelligence Β· Drug directory

FDA-Approved Drugs Directory

US FDA-approved and listed pharmaceutical products with Drugs@FDA-derived regulatory status, brand names, and pipeline cross-links.

Quick answer

FDA-approved drugs: NovaPharmaNews tracks 2,719 pharmaceutical drugs in this segment. US FDA-approved and listed pharmaceutical products with Drugs@FDA-derived regulatory status, brand names, and pipeline cross-links.

2,719 drugs Β· FDA approved Β· by data quality Β· Page 95 of 114

  1. ramucirumab

    CYRAMZA

    INJECTION FDA: approved Β· EMA: approved Β· PMDA: approved

    L01FX06
  2. ranibizumab

    LUCENTIS Novartis Pharmaceuticals

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    S01LA04
  3. ranibizumab-eqrn

    CIMERLI

    INJECTION FDA: approved

  4. ranibizumab-nuna

    BYOOVIZ

    INJECTION FDA: approved

  5. ranitidine

    APO-RANITIDINE Lacuna Pharma Pty Ltd

    ORAL FDA: approved Β· TGA: approved

  6. ranitidine bismuth citrate

    TRITEC

    ORAL FDA: approved

  7. rapacuronium bromide

    RAPLON

    INJECTION FDA: approved

  8. rasburicase

    FASTURTEC

    INTRAVENOUS FDA: approved Β· EMA: approved Β· PMDA: approved

    V03AF07
  9. ravulizumab-cwvz

    ULTOMIRIS

    INJECTION FDA: approved

  10. raxibacumab

    RAXIBACUMAB

    IV (INFUSION) FDA: approved

  11. regadenoson

    RAPISCAN

    INTRAVENOUS FDA: approved Β· EMA: approved

    C01EB21
  12. regorafenib

    STIVARGA

    ORAL FDA: approved Β· EMA: approved Β· NMPA: clinical trials

    L01EX05
  13. relugolix

    ORGOVYX

    ORAL FDA: approved Β· EMA: approved Β· PMDA: approved Β· NMPA: clinical trials

    H01CC54
  14. remdesivir

    VEKLURY

    INTRAVENOUS FDA: approved Β· EMA: approved Β· PMDA: approved

    J05AB16
  15. remibrutinib

    RHAPSIDO

    ORAL FDA: approved Β· EMA: approved

    L04AA60
  16. remifentanil hydrochloride

    REMIFENTANIL HYDROCHLORIDE

    INJECTION FDA: approved

  17. remimazolam besylate

    BYFAVO

    INTRAVENOUS FDA: approved

  18. repository corticotropin

    H.P. ACTHAR GEL

    INJECTION FDA: approved

  19. repotrectinib

    AUGTYRO

    ORAL FDA: approved Β· EMA: approved Β· PMDA: approved Β· NMPA: clinical trials

    L01EX28
  20. rescinnamine

    CINNASIL

    ORAL FDA: approved

  21. retifanlimab-dlwr

    ZYNYZ

    INTRAVENOUS FDA: approved

  22. revefenacin

    REVEFENACIN

    INHALATION FDA: approved Β· NMPA: clinical trials

  23. rezafungin acetate

    REZZAYO

    INTRAVENOUS FDA: approved

  24. ribociclib

    KISQALI Novartis Pharmaceuticals

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    L01EF02

Frequently asked questions

How many fda approved drugs are listed?

2,719 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.